Top

Published in:

01-03-2014 | Research Article

Genetic association of PLCE1, C11orf92-C11orf93, and NOC3L with colorectal cancer risk in the Han population

Authors: Xianglong Duan, Xiaolan Li, Huiling Lou, Tingting Geng, Tianbo Jin, Ping Liang, Shanqu Li, Yanbin Long, Chao Chen

Published in: Tumor Biology | Issue 3/2014

Abstract

Colorectal cancer (CRC) is a common malignant tumor that is influenced by an interaction between genetic and environmental factors. Currently, the inherited factors of CRC are unclear. Our study selected 19 tag single nucleotide polymorphisms (tSNPs) to investigate whether they were associated with CRC in the Han population. In this Han Chinese case–control study, we genotyped 203 CRC cases and 296 controls using Sequenom MassARRAY technology and analyzed their associations with CRC using χ² tests, SNPStats software, and SHEsis software. Based on χ² tests, PLCE1 -rs2077218, rs11187877 (p = 0.049) and C11orf92-C11orf93-rs3802842 (p = 0.023) correlate with CRC risk. In the genetic model analyses, we found the genotype “CC” of rs3802842 in C11orf92-C11orf93 may significantly increase CRC risk in the recessive model (p = 0.0071), whereas “GT” of rs17109928 in NOC3L may decrease the risk in the over-dominant model (p = 0.0091). Using SHEsis software, we found PLCE1 and NOC3L are strongly linked, and the “GCCATTCTGTC” haplotype may increase the risk of CRC (p = 0.049). We found three genes (PLCE1, C11orf92-C11orf93, and NOC3L) are associated with CRC susceptibility. In combination with previous reports, our results suggest that these genes may be associated with CRC in the Han population.

Zheng S, Zhang SZ, Chen K, Zhu YL, Dong Q. Research on colorectal cancer in China. Recent Adv Cancer Res Ther. 2012; 535–95.

Gsur A, Bernbart K, Baierl A, Feik E, Fuhrlinger G, Hofer P, et al. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol. 2011;35:e38–41.PubMedCrossRef

Wang X, Zbou C, Qiu G, Fan J, Tang H, Peng Z. Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology. 2008;55:2039–44.PubMed

Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet. 2012;44:770–6.PubMedCrossRef

Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008;40:1426–35.PubMedCrossRef

Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012;131:217–34.PubMedCentralPubMedCrossRef

Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet. 2009.

Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347–51.PubMedCrossRef

Adamec C. Example of the use of the nonparametric test: Test χ² for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613–9.PubMed

10.

Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928–9.PubMedCrossRef

11.

Bland JM, Altman DG. Statistical notes. The odds ratio. Brit Med J. 2000;320:1468.

12.

Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–8.PubMedCrossRef

13.

Bye H, Prescott NJ, Lewis CM, Matejcjc M, Moodley L, Robertson B. Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population. Carcinogenesis. 2012;33:2155–61.PubMedCentralPubMedCrossRef

14.

Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.PubMedCrossRef

15.

Palmer AJ, Lochhead P, Hold GL, Rabkin CS, Chow WH, Lissowska J. Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prev. 2012;21:541–4.PubMedCentralPubMedCrossRef

16.

Wang X, Zhou C, Qiu G, Yang Y, Yan D, Xing T, et al. Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. Med Oncol. 2012;29:1051–8.PubMedCrossRef

17.

Wang XL, Zhou CZ, Qiu GQ, Fan JW, Xing TH, Li T, et al. PLCE1 over-expression inhibits migration of colon cancer SW620 cells and induces their apoptosis. Tumor. 2011; 31.

18.

Peltekova V, Lemire M, Trinh Q, Qazi A, Bielecki R, HodgsonJensen L, et al. Tumor microenvironment and genetic association with colorectal cancer risk. EJC. 2012;48 Suppl 5:S25.CrossRef

19.

Tominage K, Johmura Y, Nishizuka M, Imagawa M. Fad24, a mammalian homolog of Noc3p, is a positive regulator in adipocyte differentiation. J Cell Sci. 2004;117:6217–26.CrossRef

20.

Johmura Y, Osada S, Nishizuka M, Imaqawa M. FAD24, a regulator of adipogenesis, is required for the regulation of DNA replication in cell proliferation. Biol Pharm Bull. 2008;31:1092–5.PubMedCrossRef

21.

Johmura Y, Osada S, Nishizuka M, Imagawa M. FAD24 acts in concert with histone acetyltransferase HBO1 to promote adipogenesis by controlling DNA replication. J Biol Chem. 2008;283:2265–74.PubMedCrossRef

22.

Johmura Y, Suzuki M, Osada S, Nishizuka M, Imagawa M. FAD24, a regulator of adipogenesis and DNA replication, inhibits H-RAS-mediated transformation by repressing NF-кB activity. Biochem Bioph Res Co. 2008;369:464–70.CrossRef

23.

Karin M. Nuclear factor-kappa B in cancer development and progression. Nature. 2006;441:431–6.PubMedCrossRef

24.

Wang S, Liu ZJ, Wang LS, Zhang XR. NF-κB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009;6:327–34.PubMedCrossRef

25.

Yuan LJ, Jin TB, Yin JK, Du XL, Wang Q, Dong R, et al. Polymorphisms of tumor-related genes IL-10, PSCA, MTRR, and NOC3L are associated with the risk of gastric cancer in the Chinese Han population. Cancer Epidemiol. 2012;36:e366–72.PubMedCrossRef

Title: Genetic association of PLCE1, C11orf92-C11orf93, and NOC3L with colorectal cancer risk in the Han population
Authors: Xianglong Duan
Xiaolan Li
Huiling Lou
Tingting Geng
Tianbo Jin
Ping Liang
Shanqu Li
Yanbin Long
Chao Chen
Publication date: 01-03-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 3/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1242-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells

High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients

The safety and efficacy of magnetic nano-iron hyperthermia therapy on rat brain glioma

Mitochondrial translocation of cofilin-1 promotes apoptosis of gastric cancer BGC-823 cells induced by ursolic acid

Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma

Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer